ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.570
+0.040 (2.61%)
Jun 29, 2026, 4:00 PM EDT - Market closed
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $39.67 million as of June 30, 2026. Its market cap has increased by 27.98% in one year.
Market Cap
39.67M
Enterprise Value
42.20M
1-Year Change
27.98%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $39.67M, a decrease of -50.10%. That is a compound annual growth rate of -13.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 40.80M | -21.24% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperion DeFi | 46.38M |
| Apollomics | 45.68M |
| Genenta Science | 42.70M |
| RenovoRx | 42.56M |
| Estrella Immunopharma | 42.29M |
| Actuate Therapeutics | 40.20M |
| Grace Therapeutics | 38.73M |
| INmune Bio | 37.75M |